BackBriaCell Therapeutics Warrant Overview

BriaCell Therapeutics Warrant Current Cash

BriaCell Therapeutics Warrant's current cash is $6.9M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$6.88M
↓ 44.78% YoYΔ $-5.58M vs prior year quarter

Peer trimmed avg / median

Loading

BriaCell Therapeutics Warrant Current Cash History

Loading

BriaCell Therapeutics Warrant vs. peers: Current Cash Comparison

Loading

BriaCell Therapeutics Warrant Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

BriaCell Therapeutics Warrant (BCTXZ) FAQ

As of the most recent data (April 2026), BCTXZ shows a current cash of $6.9M. That compares with $12M in the prior-year period — down 44.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BCTXZ's current cash is now $6.9M (was $12M) — a 44.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether BriaCell Therapeutics Warrant is outperforming or lagging.

Tracking BCTXZ's current cash over time shows whether BriaCell Therapeutics Warrant is scaling, shrinking, or reshaping that part of the business. The current reading is $6.9M That compares with $12M in the prior-year period — down 44.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has BriaCell Therapeutics Warrant's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $6.9M) with ownership activity and broader fundamentals.

BriaCell Therapeutics Warrant's current cash is $6.9M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.